Pharmaceutical Conferences

CGMP-compliant companies must develop / implement formal software controls and usage, starting with proper verification and validation methods. This is an important consideration for a company’s Quality Management System (QMS) and must consider applicable elements of electronic records / signatures / Part 11. The US FDA recently added data integrity and cybersecurity to these requirements. These activities must be properly documented.

Impact Conferences invites all researchers, professors, delegates to attend the Pharma, Toxicology and Clinical Trials conference which is going to held during July 15-16, 2020 at Valencia, Spain.

This webinar will familiarize participants with USP Chapter <1029> on good documentation guidelines. This session will wrap up the general concept and will provide information as to what needs to be documented in certain records.

This webinar will give a brief overview of the general procedure for the preparation and documentation of the Annual Product Quality Review and also focuses on the regulations and the regulatory requirements as per US and Europe.

Preclinical development is a critical stage of drug development that determines as well as measures the “therapeutic” doses needed and the ability to achieve these doses. Moreover, preclinical studies assess the safety of the drug at these doses.

Sample re-analysis can be a quagmire of decision and indecision. Incurred sample re-analysis is required in regulated labs, but resolution of disparate results can be another difficult area. Pre-analytical issues- including mislabeling or absent sample as well as analytical issues add a measure of difficulty as well. This presentation will address these issues and help formulate acceptable resolutions.

The goal of pharmaceutical development is to design a manufacturing process that can produce a drug product to a consistently high quality. This webinar sets out regulatory expectations for pharmaceutical development, taking account of the risk-based approach set out in ICH guidance documents (Q8, Q9, Q10 and draft Q12). It covers some examples of problems encountered during drug development.

We feel delighted to host the "10th International Conference on Pharmaceutical GMP, GCP & Regulatory Affairs" during October 19-20, 2020 at Vancouver, Canada

The World’s Definitive Antibody-Drug Conjugate Conference.

This ICFTD conference is held every two years and is the only regularly scheduled international conference devoted to FTD.

14th International Conference on Pharma and Drug Safety will be held in October 21-22, 2020 at Frankfurt, Germany. The Conference will have an intensive 2-day event with a wide scope of theme “Execution of Research, Innovation and Ideas of Drug Safety & Pharmacovigilance” covering drug store practice, pharmaceutical science, pharmacology, pharmacovigilance, and numerous other pharmaceutical improvements. The meeting additionally gives proceeding with expert improvement credits to every one of the members which demonstrate that they are skilled in their field.

Pharmaceutical Chemistry 2020 is a global overview the Theme “Illuminate the Trends in Pharmaceutical Sciences”. It is a pavement for Pharmaceutical Chemistry experts and scientific professionals to explore the research challenges & current trends and unleash advanced strategies in the arena of Pharma and Chemistry research areas. Pharmaceutical Chemistry 2020 is a specially designed cluster conference and would lay a platform for the interaction among specialists, directors, professors, faculties, experts and research fellows around the world reputed research institutes, universities and companies, agencies, association & societies. E-mail - scarlet.pharmaceuticals121@gmail.com

The PR Summit continues to be the premier platform dedicated to providing life science communicators with industry updates and best practices for successful communications strategies.

The 18th Migraine Trust International Symposium (MTIS), taking place in London from 10-13 September 2020, specialises in educational programmes about patient-focused advances in the field of migraine.

Publication: Accepted and registered papers can be published in: 1. International Journal of Applied Pharmaceutics (ISSN: 0975–7058) which can be indexed by Google Scholar, Scopus, Elsevier, EBSCO, SCI mago (SJR), CNKI (China Knowledege Resource Integrated Database), CAS, etc. 2. International Journal of Pharma Medicine and Biological Sciences (IJPMBS, ISSN: 2278-5221), which will be included in the Engineering & Technology Digital Library, and indexed by Embase (Under elsevier), ProQuest, Google Scholar, etc. 3. Biomedicines (ISSN: 2227-9059, CiteScore 3.33) as a Special Issue, indexed by Scopus (Elsevier), Science Citation Index Expanded (SCIE), PubMed, Inspec (IET), EBSCO, etc.